# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA657563 | F | Cytotoxic activity was determined in vitro in Calu-6 cell line culture at pH 6.8 | Homo sapiens | 22 | cell-based format | Scientific Literature | ||
2. | ALA656781 | F | Cytotoxic activity was determined in vitro in Calu-6 cell line culture at pH 7.4 | Homo sapiens | 22 | cell-based format | Scientific Literature | ||
3. | ALA883699 | F | Inhibitory concentration against Calu-6 cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
4. | ALA883207 | F | Ratio of inhibition by compound against Calu-6 cell line to inhibition by cisPt against Calu-6 cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
5. | ALA856639 | F | Inhibition of paxillin phosphorylation in Calu-6 xenograft tumor model at 20 mg/kg/day, po | 1 | organism-based format | Scientific Literature | |||
6. | ALA856644 | F | Inhibition of FAK phosphorylation in Calu-6 xenograft tumor model at 20 mg/kg/day, po | 1 | organism-based format | Scientific Literature | |||
7. | ALA856635 | F | Antiproliferative activity against Calu6 xenograft tumor model | 1 | cell-based format | Scientific Literature | |||
8. | ALA1828314 | F | Antiproliferative activity against human Calu6 after 48 hrs by spectrophotometry | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
9. | ALA1832690 | A | Cytotoxicity against human Calu6 cells after 48 hrs by lactate dehydrogenase assay | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
10. | ALA1943695 | F | Antitumor activity against human Calu6 cells xenografted in nude mouse assessed as tumor growth inhibition at 12.5 mg/kg bid | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
11. | ALA1943696 | F | Antitumor activity against human Calu6 cells xenografted in nude mouse assessed as tumor growth inhibition at 50 mg/kg bid | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
12. | ALA1955122 | F | Antitumor activity against human Calu6 cells xenografted in BALB/c mouse assessed as tumor growth inhibition at 600 mg/kg, po for 11 days relative to control | Homo sapiens | 5 | organism-based format | Scientific Literature | ||
13. | ALA1955123 | F | Antiangiogenic activity in human Calu6 cells xenografted in BALB/c mouse assessed as microvessel density reduction at 300 mg/kg, po after 11 days by immunohistochemical staining method | Homo sapiens | 6 | organism-based format | Scientific Literature | ||
14. | ALA1952579 | F | Antitumor activity against human Calu6 cells xenografted in BALB/c mouse assessed as tumor growth inhibition at 300 mg/kg, po for 11 days relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
15. | ALA1952591 | F | Antitumor activity against human Calu6 cells xenografted in po dosed BALB/c mouse assessed as tumor growth inhibition administered qd for 11 days | Homo sapiens | 2 | organism-based format | Scientific Literature | ||
16. | ALA1952593 | F | Antitumor activity against human Calu6 cells xenografted in BALB/c mouse assessed as tumor growth inhibition at 150 mg/kg, po qd for 11 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
17. | ALA1952594 | F | Antitumor activity against human Calu6 cells xenografted in BALB/c mouse assessed as tumor growth inhibition at 80 mg/kg, po qd for 11 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
18. | ALA1952595 | F | Antitumor activity against human Calu6 cells xenografted in BALB/c mouse assessed as tumor growth inhibition at 150 mg/kg, po qd for 11 days in presence of sunitinib | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
19. | ALA1953288 | A | Antiproliferative activity against human Calu6 cells assessed as cell growth inhibition | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
20. | ALA1953304 | F | Antiangiogenic activity in human Calu6 cells xenografted in BALB/c mouse assessed as microvessel density reduction at 1 to 10 mg/kg, po qd for 11 days measured 24 hrs after last postdose by immunohistochemical staining method | Homo sapiens | 2 | organism-based format | Scientific Literature |